Literature DB >> 33588261

Idiopathic hypersomnia: a homogeneous or heterogeneous disease?

Sona Nevsimalova1, Marek Susta2, Iva Prihodova1, Eszter Maurovich Horvat1, Martin Milata1, Karel Sonka3.   

Abstract

INTRODUCTION: Idiopathic hypersomnia (IH) is a rare orphan disease characterized by excessive daytime sleepiness, frequently accompanied by prolonged nocturnal sleep and difficulties awakening, termed sleep inertia or sleep drunkenness. Severe sleepiness usually causes a greater handicap than manifestations of narcolepsy.
METHODS: Forty-three IH patients (17 male, mean age 42.8 ± SD 12.2 years, range 20-67), diagnosed in the past 20 years according to ICSD-2 or ICSD-3 criteria were invited for clinical examination to evaluate the course, manifestations and severity of the disease, as well as clinical comorbidities. The patients completed a set of questionnaires scoring sleepiness, sleep inertia, fatigue, depression, anxiety, circadian preference, and quality of life.
RESULTS: IH patients were divided according to the duration of nocturnal sleep at the time of their diagnosis into two cohorts: (1) with normal sleep duration (n = 25, 58.1%) and (2) with long sleep duration (n = 18, 41.9%). The mean duration of ad libitum sleep per 22 h in the second cohort was 732.0 ± 115.4 min (range 603-1100), and women markedly prevailed (n = 14, 77.8%). Age at disease onset was younger in the group with long sleep duration (21.2 ± 11.4 years versus 28.1 ± 13.6 years, p = 0.028), their MSLT latency was longer (7.2 ± 3.7 min versus 5.1 ± 1.7 min, p = 0.005), a history of sleep inertia prevailed (p = 0.005), and daily naps were mostly non-refreshing (p = 0.014). Additionally, questionnaires in the group with long sleep duration showed more severe sleep inertia (p = 0.007), fatigue (p = 0.004), and a tendency towards evening chronotype (p = 0.001).
CONCLUSIONS: IH patients with long sleep duration differ clinically as well as by objective measures at the time of diagnosis and in long-term follow up from IH patients without long 24-h sleep time. In our opinion they represent an independent clinical entity to be considered in the revised ICSD-3 criteria.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical differences; ICDS-3 revision; Idiopathic hypersomnia; Objective measure distinctions; Sleep duration; Sleep inertia

Mesh:

Year:  2021        PMID: 33588261     DOI: 10.1016/j.sleep.2021.01.031

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  3 in total

1.  Idiopathic Hypersomnia-A Dynamic Simulation Model.

Authors:  Marek Susta; Karel Šonka; Gustav Bizik; Svojmil Petranek; Sona Nevsimalova
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

Review 2.  Idiopathic Hypersomnia: Historical Account, Critical Review of Current Tests and Criteria, Diagnostic Evaluation in the Absence of Biological Markers and Robust Electrophysiological Diagnostic Criteria.

Authors:  Michel Billiard; Karel Sonka
Journal:  Nat Sci Sleep       Date:  2022-02-26

3.  Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering.

Authors:  Jari K Gool; Zhongxing Zhang; Martijn S S L Oei; Stephanie Mathias; Yves Dauvilliers; Geert Mayer; Giuseppe Plazzi; Rafael Del Rio-Villegas; Joan Santamaria Cano; Karel Šonka; Markku Partinen; Sebastiaan Overeem; Rosa Peraita-Adrados; Raphael Heinzer; Antonio Martins da Silva; Birgit Högl; Aleksandra Wierzbicka; Anna Heidbreder; Eva Feketeova; Mauro Manconi; Jitka Bušková; Francesca Canellas; Claudio L Bassetti; Lucie Barateau; Fabio Pizza; Markus H Schmidt; Rolf Fronczek; Ramin Khatami; Gert Jan Lammers
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.